Cite

HARVARD Citation

    de Jong, J. et al. (2020). Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6. Pharmacology research & perspectives. 8 (5), p. n/a. [Online]. 
  
Back to record